RemeGen Co. Ltd. Class A
688331
Hisse Senetlerindeki Sıralama
#2353
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces,... RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People's Republic of China.
Hisse Fiyatı
$14.83
Piyasa Değeri
$8.30B
Değişim (1 gün)
-2.79%
Değişim (1 yıl)
11.10%
Ülke
CN
Ticaret RemeGen Co. Ltd. Class A (688331)
Kategori
Healthcare
RemeGen Co. Ltd. Class A (688331) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $14.99 - 2026-10-01
Gün sonu en düşük fiyat: $6.44 - 2022-03-01
Gün sonu en düşük fiyat: $6.44 - 2022-03-01
RemeGen Co. Ltd. Class A için hisse fiyatı geçmişi: 2022 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2026 (TTM) | 33.53% |
| 2025 | 157.04% |
| 2024 | -48.44% |
| 2023 | -13.90% |
| 2022 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.40 | -4.08% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
